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Abstract We have investigated the regulation mechanism of the
surface sialyl-LeX (sLeX) expression level in tonsillar B cells
during activation. sLeX antigen became strongly positive after
activation, while resting B cells were weakly positive. sLeX
structures were mainly located on O-linked oligosaccharide
chains of glycoprotein. Transcripts of FucT-VII and core 2
GlcNAc transferase (C2GnT) were up-regulated after activation,
while those of ST3GalIV and L1C4GalT-I were expressed
constitutively. However, the up-regulation of C2GnT was more
dramatic than that of FucT-VII. These results suggest that sLeX
expression level is regulated by C2GnT during tonsillar B cell
activation.
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1. Introduction
Cell surface glycoproteins and glycosphingolipids play im-
portant roles on presenting functional oligosaccharide struc-
tures mostly as sugar chain termini. Hematopoietic cells ex-
press such terminal oligosaccharide structures as
di¡erentiation markers in a lineage-speci¢c and stage-speci¢c
manner [4]. There are key glycosyltransferases for the control
of lineage-speci¢c sugar chain expression during di¡erentia-
tion. In some human and murine leukemia cell lines, the
most upstream glycosyltransferases critically determine the
level of terminal carbohydrate expression by modulating total
metabolic £ow of glycosphingolipid biosynthesis at upstream
branching steps [5^8].
Sialyl-LeX (sLeX ; CD15s) antigen determinant is biosynthe-
sized by the action of sequential glycosyltransferases at the
terminus of the type I poly-N-acetyllactosamine backbone of
the oligosaccharide chain attached to glycoproteins or glyco-
sphingolipids. Recently, we have reported that cell surface
CD15s is expressed mostly on the O-linked oligosaccharide
of glycoproteins and its expression level is regulated by a
single glycosyltransferase, core 2 L1C6-N-acetylglucosami-
nyltransferase (C2GnT) [9], during di¡erentiation of human
pre-B lymphocytic leukemia cell lines [10,11]. Namely, the
terminal K1C3-fucosyltransferase, FucT-VII [12], and
K2C3-sialyltransferase, ST3GalIV [13], were constitutively
expressed and did not show signi¢cant changes in their ex-
pression levels during pre-B cell di¡erentiation. Instead,
C2GnT expression was signi¢cantly down-regulated and the
decrease was in good correlation with down-regulation of the
surface sLeX level. However, it was uncertain whether C2GnT
plays such a regulatory role on sLeX expression not only in
pre-B cell di¡erentiation but also in B cell activation. In the
present study, we have investigated glycosyltransferase expres-
sion during human tonsillar B cell activation and obtained
data suggesting that the cell surface CD15s level is regulated
by C2GnT during tonsillar B cell activation as well as during
pre-B cell di¡erentiation.
2. Materials and methods
2.1. Cells
Human tonsils were surgically obtained in Jichi Medical School
Hospital and used for research purposes according to the informed
consent guideline of the hospital. Mononuclear cells were isolated by
Ficoll^Conray gradient sedimentation, and tonsillar B cells were pu-
ri¢ed using Dyna-beads M450 Pan-B CD19 (Veritas, Oslo, Norway)
after activation with 1% (v/v) pokeweed mitogen (PWM; Life Tech-
nology, Rockville, MD, USA). For inhibition of sugar chain biosyn-
thesis, tonsillar mononuclear cells were cultured with inhibitors for
4 days in the presence of PWM as described [10,11]; 10 Wg/ml swain-
sonine (Genzyme, Cambridge, MA, USA), 4 mM benzyl-K-GalNAc
(Bz-K-GalNAc; Sigma, St. Louis, MO, USA), or 20 WM D-threo-1-
phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP; Seikaga-
ku, Tokyo, Japan). Human pre-B NALL1 and Nalm1 cell lines
(strongly positive for sLeX), and the mature lymphoblastoid cell line
KJM-LCL and Burkitt’s lymphoma cell line Raji (only weakly pos-
itive for sLeX) were obtained and cultured as described [10].
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2.2. Flow cytometry analyses
Immuno£uorescence analyses of cell surface di¡erentiation antigen
expression were carried out by FACScan (Becton Dickinson) as de-
scribed previously [5]. The monoclonal antibodies against di¡erentia-
tion antigens were KM93 (CD15s; Seikagaku, Tokyo, Japan), J4.119
(CD19; Immunotech, Marseilles, France), OKBcALLa (CD10; Ortho
Diagnostics Systems, Tokyo, Japan), and WEHI-B2 (CD21; Japan
Turner, Suita, Japan). The second antibody was £uorescein isothio-
cyanate-conjugated goat F(abP)2 anti-mouse IgG plus IgM (Tago,
Inc., Burlingame, CA, USA). Mouse anti-IgG monoclonal antibody
(IgM) was obtained from Sigma (St. Louis, MO, USA) and used as a
control ¢rst antibody. R-phycoerythrin-conjugated SJ25-C1 (CD19;
Sigma, St. Louis, MO, USA) monoclonal antibody was used for
counter staining in two-color analysis.
2.3. [3H]Thymidine (dThd) incorporation
Activation of B cells was characterized by [3H]dThd uptake as
described [14] with modi¢cation. Mononuclear cells were incubated
with [3H]dThd in the presence or absence of PWM. After 4 days
incubation, CD19 positive cells were puri¢ed and [3H]dThd incorpo-
ration into 5U105 cells was measured by liquid scintillation counting.
2.4. Semi-quantitative reverse-transcribed PCR analysis
Semi-quantitative reverse-transcribed PCR analyses of glycosyl-
transferases, FucT-VII, ST3GalIV, L1C4GalT-I [15], and C2GnT
were conducted using the respective primer pairs as described [10,11].
2.5. Glycosyltransferase activity and protein assays
The total membranous fractions were prepared, aliquoted, and
stored at 380‡C until use for glycosyltransferase assays as described
previously [6]. K1C3-Fucosyltransferase and C2GnT activities were
determined using acceptor substrates, NeuAcK2C3GalL1C4Glc-
NAcL1C3GalL1C4Glc-pyridylamine and GalL1C3GalNAcK1Cp-
nitrophenol, respectively, as described [10,11]. Protein was determined
by an amido-Schwarz dye binding method [16] with bovine serum
albumin as a standard.
3. Results
3.1. Expression of CD15s on human tonsillar B cells
Tonsillar B cells surgically obtained from volunteers were
CD19CD103CD21. In the puri¢ed B cell fractions, there
was little contamination of CD10 pre-B cells and CD3 T
cells. Donors exhibited various degrees, from very weak to
very strong, of positivity for CD15s in the B cell fractions
even before activation by PWM. We considered that this
may be caused by some acute or chronic infection or non-
infectious status; tonsillar B cells of such donors may be ac-
tivated to various grades by subclinical infection or by other
stimuli before surgery. Consequently, we chose several cases
whose B cell fractions were only weakly positive for CD15s. A
typical example is presented in Table 1 and Fig. 1. When the
tonsillar B cells were activated by PWM in vitro, increased
[3H]dThd uptake was observed (Table 1). As shown in Fig. 1,
isolated CD19 cells were signi¢cantly converted from weakly
positive for anti-CD15s KM93 monoclonal antibody to
strongly positive after PWM stimulation. By contrast, tonsil-
lar B cells from some patients with infectious and non-malig-
nant disease were strongly positive with KM93 monoclonal
antibody (data not shown). This positivity may be due to B
cell activation in tonsils of the patients.
To investigate the location of the antigenic determinants,
tonsillar B lymphocytes from healthy donors were activated in
vitro by PWM in the presence of Bz-K-GalNAc, swainsonine,
or PDMP, and analyzed by £ow cytometry (Table 1). Bz-K-
GalNAc treatment signi¢cantly reduced CD15s expression,
while the expression was not in£uenced by swainsonine or
PDMP. These results strongly suggest that tonsillar B cells
express sLeX antigenic determinant(s) not on glycosphingolip-
ids or N-glycans but on O-linked oligosaccharide chains of
glycoproteins.
3.2. Expression of glycosyltransferases involved in sLeX
biosynthesis
To investigate the enzymatic background of sLeX synthesis
during tonsillar B cell activation, expression of glycosyltrans-
ferase gene transcripts involved in sLeX biosynthesis was an-
alyzed by semi-quantitative reverse-transcribed PCR analyses.
FucT-VII, ST3GalIV, L1C4GalT-I, and C2GnT transcripts
were examined using total RNA from activated tonsillar B
lymphocytes, as shown in Fig. 2 (two right-hand lanes).
Standard GAPDH was constitutively ampli¢ed and its radio-
activity levels were used for normalization of glycosyltransfer-
ase expression. The resting tonsillar B lymphocytes did not
express C2GnT transcript, while FucT-VII, ST3GalIV, and
L1C4GalT-I transcripts were strongly detected. By contrast,
PCR product of C2GnT was signi¢cantly ampli¢ed in PWM-
stimulated tonsillar B lymphocytes. Although the FucT-VII
PCR product expression level in the activated tonsillar B cells
was enhanced compared with that in the resting cells, the
enhancement was not as signi¢cant as in C2GnT. However,
the expression level of ST3GalIV and L1C4GalT-I tran-
scripts was constitutive throughout the activation. When we
compare B cell activation with pre-B cell di¡erentiation, the
strong and constitutive expression of ST3GalIV and
L1C4GalT-I during B cell activation was more remarkable
than that in pre-B cell di¡erentiation (Fig. 2, four left-hand
lanes).
Subsequently, glycosyltransferase activities of K1C3-fuco-
syltransferase and C2GnT were examined using the resting
Table 1
Expression of di¡erentiation markers and [3H]dThd incorporation in tonsillar B cells during activation
PWM treatment CD10 CD19 CD21 CD15s [3H]dThd incorporationb
no inhibitora N-glycana O-glycana glycolipida cpm/5U105 cells
Tonsillar B (3) 3 ++++ ++ + N.D.c N.D.c N.D.c 351 þ 57.8*
Tonsillar B (+) 3 ++++ ++ +++ +++ + +++ 82 263 þ 4307*
Tonsillar mononuclear cells were cultured in the presence or absence of PWM for 4 days and CD19 positive cells were puri¢ed by Dyna-beads
M450 Pan-B and then analyzed by £ow cytometry. The expression was analyzed by £ow cytometry and shown in a semi-quantitative manner:
++++, more than 80% positive cells ; +++, 40^80% positive; ++, 20^40% positive; +, 5^20% positive; 3, less than 1% positive cells.
aTonsillar mononuclear cells were cultured for 4 days with or without treatment by sugar chain processing inhibitors, swainsonine (N-glycan),
Bz-K-GalNAc (O-glycan), or PDMP (glycolipid) in the presence of PWM. CD15s expression was analyzed by £ow cytometry.
bTonsillar mononuclear cells were labeled with [3H]dThd and cultured in the presence or absence of PWM. After 4 days culture, CD19 positive
cells were puri¢ed using Dyna-beads M-450 Pan-B CD19 and then radioactivity was counted with a liquid scintillation counter. The values are
expressed as means of triplicate assays þ S.D. Statistical analyses were conducted with Student’s t-test; *P6 0.01.
cN.D.; not done.
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and stimulated tonsillar B lymphocytes (Fig. 3). K1C3-Fuco-
syltransferase activities in the PWM-activated tonsillar B cells
were about 60% higher than those in the resting cells. On the
other hand, C2GnT activities in the stimulated B lymphocytes
from tonsils were about 10 times higher than those in the non-
activated cells.
4. Discussion
According to the present results, expression level of surface
sLeX in mature tonsillar B cells is regulated by C2GnT during
cell activation as well as during pre-B cell di¡erentiation. For
di¡erentiation of pre-B cells, we con¢rmed the role of C2GnT
not only by comparing a set of pre-B lymphoid cell lines with
that of mature B cell lines [10] but also by gene transfection
and overexpression using a pre-B lymphoid cell line that is
capable of di¡erentiating into a more mature stage [11]. For
mature B cell activation, however, we used tonsillar B cells in
the present study and could not prove the C2GnT role by
gene transfection and overexpression. If we use any cell line
to be activated in vitro, we would be able to demonstrate the
key involvement of C2GnT in a deeper level. However, this
remains to be elucidated.
During T cell activation, it was reported that FucT-VII is
the key regulatory glycosyltransferase for determination of
sLeX expression [17] and that both FucT-VII and C2GnT
are up-regulated [18]. That is, in addition to FucT-VII, an
increase in C2GnT message and activity is required for surface
sLeX expression in T cell activation. Regarding B cell activa-
tion, both FucT-VII and C2GnT were up-regulated (Figs. 2
and 3) as well as in T cells. However, FucT-VII up-regulation
in B cells did not seem to be as signi¢cant as that in T cells
[18]. Namely, while the FucT-VII message and enzyme activ-
ity level is high enough before activation, B cell surface sLeX
expression seems to be weak due to little C2GnT activity.
After up-regulation of C2GnT, sLeX is signi¢cantly expressed
on the activated B cell surface. It may be true that the di¡er-
ence between T and B cells is derived from that of materials :
peripheral blood T cells and tonsillar B cells, respectively.
Because the percentage of B cell fraction is too low, we did
not use peripheral blood in the present study. However, to
compare B cells with T cells using the same peripheral blood
would be of interest to elucidate and compare sLeX expression
mechanisms during activation of T and B lymphocytes.
Gene families for all glycosyltransferase that form the same
sugar linkage are reported. Among them, the C2GnT and
L1C4-galactosyltransferase gene families have recently been
demonstrated [3,19] and are closely related to the present
work. For C2GnT, Yeh et al. described mucin-type C2GnT
[19] in addition to conventional leukocyte-type C2GnT [9].
Regarding the L1C4-galactosyltransferase gene family, Ujita
et al. [20] reported that poly-N-acetyllactosamine in core 2
branched O-glycans is synthesized by L1C3-N-acetylglucos-
aminyltransferase [21] in combination not with L1C4GalT-I
[15] but with L1C4GalT-IV [3]. On the other hand, Kotani et
al. revealed that L1C4GalT-I is predominantly responsible
for L1C4-galactosylation of core 2 O-glycan branches by
analyzing erythrocytes from L1C4GalT-I knock-out mice
[22]. According to the latter results, we analyzed only the
L1C4GalT-I transcript level in the present report. However,
Fig. 1. CD15s expression in activated human tonsillar B cells from a healthy donor. Tonsillar mononuclear cells were cultured in the presence
or absence of PWM for 4 days. CD19 cells were then puri¢ed and analyzed by two-color immuno£uorescence £ow cytometry. Left panel: no
stimulation; right panel: stimulated by PWM.
Fig. 2. Semi-quantitative reverse-transcribed PCR analyses of glyco-
syltransferases involved in sLeX synthesis in tonsil B cells. For com-
parison, data using pre-B and mature B lymphoid cell lines are pre-
sented in the left four lanes. RNA from the cells was reverse-
transcribed and cDNA was subjected to PCR reaction. Polyacryl-
amide gel electrophoresis was conducted, and the products were
visualized by autoradiography (FucT-VII, 0.44 kb; ST3GalIV, 0.47
kb; L1C4GalT-I, 0.5 kb; C2GnT, 0.6 kb; GAPDH, 0.6 kb).
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re-evaluation by analyzing expression levels of such gene fam-
ilies would be required for further elucidation of sLeX expres-
sion mechanism in lymphocytes.
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Fig. 3. K1C3-Fucosyltransferase and C2GnT activities in tonsillar B cells after stimulation by PWM. The activities were measured using re-
spective pyridylaminated or p-nitrophenyl oligosaccharides as acceptors and total membranous fractions as enzyme preparations. K1C3FucT,
K1C3-fucosyltransferase. The values are expressed as pmol/mg protein/h and as means of triplicate assays þ S.D.
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